Shire Gains Anti-Scarring Product, Juvista®
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 86 (Table of Contents)
Published: 7 Aug-2007
DOI: 10.3833/pdr.v2007.i86.307 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Shire has signed an agreement with Renovo Group for its drug candidate Juvista® (human TGFbeta3) for the prevention and reduction of scarring...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018